BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24758762)

  • 1. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
    Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
    Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
    Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
    Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
    Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
    Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
    Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
    Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
    Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
    Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.
    Lin NY; Lee JJ; Chen ST; Lin JA; Lin CH; Lin HY; Su YH; Chen CC; Lin MC; Kuo CY; Huang MC
    Mol Cancer Res; 2023 Jul; 21(7):664-674. PubMed ID: 37040171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.
    Milde-Langosch K; Schütze D; Oliveira-Ferrer L; Wikman H; Müller V; Lebok P; Pantel K; Schröder C; Witzel I; Schumacher U
    Breast Cancer Res Treat; 2015 Jun; 151(3):515-28. PubMed ID: 25975956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
    Salvini R; Bardoni A; Valli M; Trinchera M
    J Biol Chem; 2001 Feb; 276(5):3564-73. PubMed ID: 11058588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression.
    Wan Y; Adair K; Herrmann A; Shan X; Xia L; Duckworth CA; Yu LG
    Cell Death Dis; 2023 Aug; 14(8):547. PubMed ID: 37612278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.
    Tian H; Yu JL; Chu X; Guan Q; Liu J; Liu Y
    Front Oncol; 2024; 14():1389713. PubMed ID: 38699634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.